Clinical Trial Update: A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase II multi-institutional study evaluating cyclophosphamide, paclitaxel, and cisplatin with G-CSF in newly diagnosed advanced-stage ovarian cancer has been c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Filgrastim (filgrastim)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ovarian Neoplasm | Phase 2 | Status: COMPLETED